- Mass spectrometry, a powerful analytical technique used to identify and quantify chemical compounds, is becoming increasingly important in the Middle East and Africa for applications across pharmaceuticals, environmental testing, food safety, and clinical diagnostics due to its high sensitivity, accuracy, and ability to analyze complex mixtures
- The growing demand for mass spectrometry is primarily driven by expanding healthcare and research sectors, rising incidence of chronic and infectious diseases, and increasing regulatory emphasis on drug safety and environmental monitoring
- Saudi Arabia dominated the Middle East and Africa mass spectrometry market with the largest revenue share of 35.1% in 2024, supported by strong government investments in healthcare infrastructure, pharmaceutical research, and the establishment of modern laboratories through national health and science initiatives
- South Africa is expected to be the fastest-growing country in the Middle East and Africa mass spectrometry market during the forecast period due to growing research activities, academic collaborations, and the need for advanced diagnostic tools
- The hybrid mass spectrometry segment dominated the Middle East and Africa mass spectrometry market with a market share of 41.7% in 2024, driven by its superior analytical performance and widespread use in clinical diagnostics, proteomics, and drug discovery applications across GCC countries and South Africa
